Yes, analyst is legitimate. If you take the 1.22 to mid 1.30's 2 day hop as a daytrade its 7-10 %. If you go long likely minimum 30-40%. Could go back to 2.70 on anticipation of APPY 1 data expected later in the year. Price is sooo close to the actual cash per share there seems very little risk. And they are fairly late stage. Safest play, ... Let it run and cash out before data released. Just check their PR for dates or biopharmcatalyst or biotechnologyevents. Happy trading.